Triptorelin GnRH — 100 mcg

Triptorelin is a ten-amino-acid analogue of gonadotropin-releasing hormone, also called luteinizing-hormone-releasing hormone. A D-tryptophan substitution distinguishes it from the native sequence. Umbrella presents it as a reproductive-axis research peptide and links it to hormone-dependent conditions. Its core pharmacology is GnRH-receptor agonism at the pituitary, not direct replacement of testosterone or estrogen.

The response changes with the pattern and duration of receptor stimulation. Early exposure stimulates LH and FSH release, whereas sustained stimulation desensitizes the pituitary response and lowers gonadal hormone production. The National Cancer Institute describes this mechanism in relation to suppression of testosterone-dependent prostate-cancer growth. Clinical formulations have also been used for central precocious puberty, as described by MedlinePlus. These contexts explain the research emphasis on endocrine suppression, reproductive-axis control, and hormone-sensitive disease. They also show why describing triptorelin simply as a testosterone booster would be misleading. A research-vial product is not interchangeable by description alone with a regulated extended-release pharmaceutical formulation.